Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@pick1998_2 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::425402956.png) @pick1998_2 Nick zheng

Nick zheng posts on X about $srpt, discount, aav, $clrb the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::425402956/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::425402956/c:line/m:interactions.svg)

- X Week XXXXXX +513%
- X Month XXXXXX +246%
- X Months XXXXXX +282%
- X Year XXXXXX -XX%

### Mentions: X [#](/creator/twitter::425402956/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::425402956/c:line/m:posts_active.svg)


### Followers: XXXXX [#](/creator/twitter::425402956/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::425402956/c:line/m:followers.svg)

- X Week XXXXX +0.45%
- X Month XXXXX +1.30%
- X Months XXXXX +4.10%
- X Year XXXXX +5.70%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::425402956/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::425402956/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::425402956/influence)
---

**Social category influence**
[stocks](/list/stocks) 

**Social topic influence**
[$srpt](/topic/$srpt), [discount](/topic/discount), [aav](/topic/aav), [$clrb](/topic/$clrb), [drugs](/topic/drugs), [$ghrs](/topic/$ghrs), [$mreo](/topic/$mreo), [c3](/topic/c3), [$apls](/topic/$apls)

**Top assets mentioned**
[Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Apellis Pharmaceuticals, Inc. Common Stock (APLS)](/topic/$apls)
### Top Social Posts [#](/creator/twitter::425402956/posts)
---
Top posts by engagements in the last XX hours

"$SRPT pivoting from AAV gene therapy/RNA splicing to siRNA therapies and broadened applications. A good direction. strong buy under 30"  
![@pick1998_2 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::425402956.png) [@pick1998_2](/creator/x/pick1998_2) on [X](/post/tweet/1945600798219800844) 2025-07-16 21:45:52 UTC 6902 followers, 6710 engagements


"$CLRB insiders are buying after r-split and financing at discount. Will FDA BTD bring this biotech stock back to life"  
![@pick1998_2 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::425402956.png) [@pick1998_2](/creator/x/pick1998_2) on [X](/post/tweet/1940816738163347904) 2025-07-03 16:55:43 UTC 6902 followers, 1327 engagements


"$GHRS has huge potential. Quicker Psychedelic Drugs Offer Investors a Better Trip Shorter-duration highscould help unlockcommercial viability for the sector"  
![@pick1998_2 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::425402956.png) [@pick1998_2](/creator/x/pick1998_2) on [X](/post/tweet/1943057552872518118) 2025-07-09 21:19:55 UTC 6902 followers, XXX engagements


"$SRPT black box warning for Elevidys label resolving any materials issues. Back to 70"  
![@pick1998_2 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::425402956.png) [@pick1998_2](/creator/x/pick1998_2) on [X](/post/tweet/1945576114300358716) 2025-07-16 20:07:47 UTC 6902 followers, 2392 engagements


"$MREO buy it now at XX% discount and forget it for a few months. Very likely it will recover when topline final data are announced by end of this year"  
![@pick1998_2 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::425402956.png) [@pick1998_2](/creator/x/pick1998_2) on [X](/post/tweet/1944774197437448259) 2025-07-14 15:01:15 UTC 6902 followers, 3587 engagements


"$APLS PUDFA 7/28/25 sNDA of EMPAVELI(pegcetacoplan) for C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) which are severe and rare kidney diseases. Priority Review. Approval should come. It should help reach profitability"  
![@pick1998_2 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::425402956.png) [@pick1998_2](/creator/x/pick1998_2) on [X](/post/tweet/1946231638557618231) 2025-07-18 15:32:36 UTC 6902 followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@pick1998_2 Avatar @pick1998_2 Nick zheng

Nick zheng posts on X about $srpt, discount, aav, $clrb the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Week XXXXXX +513%
  • X Month XXXXXX +246%
  • X Months XXXXXX +282%
  • X Year XXXXXX -XX%

Mentions: X #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

  • X Week XXXXX +0.45%
  • X Month XXXXX +1.30%
  • X Months XXXXX +4.10%
  • X Year XXXXX +5.70%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence stocks

Social topic influence $srpt, discount, aav, $clrb, drugs, $ghrs, $mreo, c3, $apls

Top assets mentioned Sarepta Therapeutics, Inc. (SRPT) Apellis Pharmaceuticals, Inc. Common Stock (APLS)

Top Social Posts #


Top posts by engagements in the last XX hours

"$SRPT pivoting from AAV gene therapy/RNA splicing to siRNA therapies and broadened applications. A good direction. strong buy under 30"
@pick1998_2 Avatar @pick1998_2 on X 2025-07-16 21:45:52 UTC 6902 followers, 6710 engagements

"$CLRB insiders are buying after r-split and financing at discount. Will FDA BTD bring this biotech stock back to life"
@pick1998_2 Avatar @pick1998_2 on X 2025-07-03 16:55:43 UTC 6902 followers, 1327 engagements

"$GHRS has huge potential. Quicker Psychedelic Drugs Offer Investors a Better Trip Shorter-duration highscould help unlockcommercial viability for the sector"
@pick1998_2 Avatar @pick1998_2 on X 2025-07-09 21:19:55 UTC 6902 followers, XXX engagements

"$SRPT black box warning for Elevidys label resolving any materials issues. Back to 70"
@pick1998_2 Avatar @pick1998_2 on X 2025-07-16 20:07:47 UTC 6902 followers, 2392 engagements

"$MREO buy it now at XX% discount and forget it for a few months. Very likely it will recover when topline final data are announced by end of this year"
@pick1998_2 Avatar @pick1998_2 on X 2025-07-14 15:01:15 UTC 6902 followers, 3587 engagements

"$APLS PUDFA 7/28/25 sNDA of EMPAVELI(pegcetacoplan) for C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) which are severe and rare kidney diseases. Priority Review. Approval should come. It should help reach profitability"
@pick1998_2 Avatar @pick1998_2 on X 2025-07-18 15:32:36 UTC 6902 followers, XXX engagements

creator/x::pick1998_2
/creator/x::pick1998_2